Importantly, CDK7 inhibition demonstrated potent anti‐tumour effects in preclinical GBM models, independently of MGMT promoter methylation status, by disrupting transcription, inducing apoptosis, and suppressing stemness.1, 2, 3, 4. Here, CDK7 is linked to glioblastoma.